ĀÜĄņĀŅĀ×

Dr. Petkevich has more than 30 years of financial and investment experience in biotechnology and investment banking. He is currently the Chief Investment Officer of V2M CapitalĀ®, an investment firm funding life science companies. He previously co-founded BladeRock Capital, LLC, the predecessor investment firm to V2M CapitalĀ®. Prior to BladeRock Capital, Dr. Petkevich founded The Petkevich Group, a biotechnology advisory firm, where he was Chairman and Chief Executive Officer. Dr. Petkevich previously served as Managing Director, as well as Head of Healthcare and Investment Banking, at Robertson Stephens & Co. Dr. Petkevich began his career at Hambrecht & Quist, an investment bank, where he served as a Principal, Head of Healthcare Banking and as an Institutional Investor ranked biotechnology analyst covering Genentech, Chiron and others. Dr. Petkevich received his bachelorā€™s degree from Harvard University and his D.Phil. from the University of Oxford as a Rhodes Scholar. He also is a member of the Board of Directors at Cohbar, Inc.